drugset

drugset / Trial / NCT02885857

Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney Disease

NCT02885857 ↗

Phase 4 Unknown 1500 enrolled Chen Xiangmei Tianjin TongRenTang Group Co., Ltd. · collab

NaSingle-groupOpen-labelTreatment

Summary

Safety and efficacy of long-term application of Shenyankangfu Tablets in Large sample of patients with chronic kidney disease.

Timeline

Start: 2015-06
Primary completion: 2016-12
Completion: 2016-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Shenyan Kangfu Tablets	Unknown	0.48 g	Oral

Indications